Company / Net Income
Amneal Pharmaceuticals, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$72.1M
FY2025
5-year range
-$603.6M / $72.1M
FY2021-FY2025
Trend
+161.6%
vs FY2024
Sector context
#46 of 216
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s net income of $72M is higher than 79% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$604M in FY2021 to $72M in FY2025.
Based on SEC 10-K filings.
$72M in FY2025. Top quartile in the Health Care sector.
Improved from $13M to $72M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 216This company $72.1M Sector average $454.3M
▼
-84.1% below sector average
Key checks
Key Insights
- In FY2025, net income increased 161.6% year-over-year.
- Ranks #46 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $72.1M | +161.6% |
| FY2024 | -$116.9M | -988.0% |
| FY2023 | $13.2M | +104.9% |
| FY2022 | -$270.6M | +55.2% |
| FY2021 | -$603.6M | -2957.0% |
| FY2020 | -$19.7M | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026